Feasibility of Delivering VergeRx at FQHCs

NCT06161675 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use Cessation

Interventions

BEHAVIORAL: QuitAid
BEHAVIORAL: SmokefreeTXT
DRUG: Nicotine Replacement Therapy Patch
DRUG: Nicotine lozenge

Sponsor

University of Virginia